(Total Views: 388)
Posted On: 03/21/2019 3:54:14 PM
Post# of 72448
Incubus post #54180 thoroughly spelled out that smokenhot’s earlier post today was not clearly written so I have nothing further to add to that regarding today’s food-fight. I did find it interesting that Lemoncat quickly came to smokenhot’s defense and started bashing Drano when he correctly pointed out a flawed post. I found it interesting that Lemoncat was defending a poster he called “smokenscott” and who called him a “bozo”. I am wondering if it would be less confusing to themselves if they stuck to the roles of good basher/ bad basher?
=========================================================================================
Posted On: 03/21/2019 11:32:44 AM
Posted By: Lemoncat
Re: Drano #54153
He was talking about the interval/frequency of the Cisplatin dosing - the only thing different about the two non-placebo B-OM arms. I think it was very clear to anyone who understands the B-OM trial.
Read More: https://investorshangout.com/post/view?id=538...z5ipugntwy
Posted On: 02/28/2019 4:59:29 PM
Posted By: Lemoncat
Smokenscott should be ignored.
Read More: https://investorshangout.com/post/view?id=536...z5ipkwXjEz
Posted On: 03/12/2019 6:57:06 PM
Posted By: smokenhot
Re: Lemoncat #53888
Lemon if Kevetrin could activate p53 in 20% of patients without sae that would be considered amazing since there is NO drug that can do that today.
Well guess what those 2 patients are 20% at a minimal that the trial(10) would have showed.
It was a tough tough patient population to get volunteers from.
A pill form will make it EZ to administer and Kevetrin will show it's true worth to bozo's like yourself.
Read More: https://investorshangout.com/post/view?id=537...z5iptkZgCn
=========================================================================================
Posted On: 03/21/2019 11:32:44 AM
Posted By: Lemoncat
Re: Drano #54153
He was talking about the interval/frequency of the Cisplatin dosing - the only thing different about the two non-placebo B-OM arms. I think it was very clear to anyone who understands the B-OM trial.
Read More: https://investorshangout.com/post/view?id=538...z5ipugntwy
Posted On: 02/28/2019 4:59:29 PM
Posted By: Lemoncat
Smokenscott should be ignored.
Read More: https://investorshangout.com/post/view?id=536...z5ipkwXjEz
Posted On: 03/12/2019 6:57:06 PM
Posted By: smokenhot
Re: Lemoncat #53888
Lemon if Kevetrin could activate p53 in 20% of patients without sae that would be considered amazing since there is NO drug that can do that today.
Well guess what those 2 patients are 20% at a minimal that the trial(10) would have showed.
It was a tough tough patient population to get volunteers from.
A pill form will make it EZ to administer and Kevetrin will show it's true worth to bozo's like yourself.
Read More: https://investorshangout.com/post/view?id=537...z5iptkZgCn
(5)
(0)
